Results for "Red Light Therapy" in Diabetes

20 articles

Six Weeks of Endurance Training Activates Brown Fat for Better Metabolism
Metabolic Health

Six Weeks of Endurance Training Activates Brown Fat for Better Metabolism

New study reveals how endurance exercise transforms fat-burning brown adipose tissue in just six weeks of training.

Clinical Trial
Mar 29, 2026 0
RNA Drug Targets ANGPTL3 to Slash Triglycerides in Rare Fat Disorder
Metabolic Health

RNA Drug Targets ANGPTL3 to Slash Triglycerides in Rare Fat Disorder

A Phase 2 trial tests a GalNAc-conjugated antisense therapy in familial partial lipodystrophy patients with dangerously high triglycerides.

Clinical Trial
Jun 23, 2026 0
Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes
Metabolic Health

Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes

A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.

Clinical Trial
Jun 14, 2026 0
Can Two Weeks of Exercise Restore Mitochondrial Quality Control? (Trial Registration)
Metabolic Health

Can Two Weeks of Exercise Restore Mitochondrial Quality Control? (Trial Registration)

A completed OSU trial investigates whether short-term exercise training can restore impaired mitochondrial cleanup pathways in overweight and obese skeletal muscle.

Clinical Trial
Jun 15, 2026 0
Once-Weekly HIIT Reduces Body Fat and Liver Fat in 12-Month Study
Metabolic Health

Once-Weekly HIIT Reduces Body Fat and Liver Fat in 12-Month Study

New research shows high-intensity interval training just once per week can improve obesity and fatty liver disease over a full year.

Clinical Trial
Mar 28, 2026 2
12 Weeks of Aerobic Exercise May Tame RAGE-Driven Inflammation in Type 2 Diabetes
Metabolic Health

12 Weeks of Aerobic Exercise May Tame RAGE-Driven Inflammation in Type 2 Diabetes

A completed University of Michigan trial explored how aerobic exercise training alters RAGE-mediated inflammatory pathways in type 2 diabetic adults.

Clinical Trial
Jun 4, 2026 0
Time-Restricted Mediterranean Diet Shows Promise for Fatty Liver Disease Treatment
Metabolic Health

Time-Restricted Mediterranean Diet Shows Promise for Fatty Liver Disease Treatment

New study tests whether meal timing combined with Mediterranean diet can reverse fatty liver disease better than diet alone.

Clinical Trial
Mar 29, 2026 3
New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial
Metabolic Health

New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial

275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.

Clinical Trial
Mar 28, 2026 2
Time-Restricted Eating Shows Promise for Metabolically Unhealthy Obesity
Metabolic Health

Time-Restricted Eating Shows Promise for Metabolically Unhealthy Obesity

16-week study explores how 8-hour eating windows affect different types of obesity and metabolic health markers.

Clinical Trial
Mar 29, 2026 1
App-Guided Diet Program Targets Type 2 Diabetes Reversal Without Formula Shakes
Metabolic Health

App-Guided Diet Program Targets Type 2 Diabetes Reversal Without Formula Shakes

German researchers test whether natural foods plus digital coaching can match diabetes remission rates of formula diets.

Clinical Trial
Mar 29, 2026 1
Time-Restricted Eating Shows Promise for Type 2 Diabetes Management
Metabolic Health

Time-Restricted Eating Shows Promise for Type 2 Diabetes Management

Small study explores whether eating within 9-hour windows can improve blood sugar control and metabolic health in diabetic patients.

Clinical Trial
Mar 28, 2026 0
Time-Restricted Eating Shows Promise for Weight Loss Without Calorie Counting
Metabolic Health

Time-Restricted Eating Shows Promise for Weight Loss Without Calorie Counting

UCSF study tests whether eating within specific time windows can help obese adults lose weight more effectively than traditional dieting.

Clinical Trial
Mar 28, 2026 0
New Anemia Drug GSK1278863 Tested as Replacement for EPO in Kidney Disease Patients
Metabolic Health

New Anemia Drug GSK1278863 Tested as Replacement for EPO in Kidney Disease Patients

A Phase IIa trial explores whether the HIF-PHI drug daprodustat can safely replace EPO injections in hemodialysis patients with anemia.

Clinical Trial
May 26, 2026 0
Intermittent Fasting vs Calorie Restriction Shows Promise for Black Adults
Metabolic Health

Intermittent Fasting vs Calorie Restriction Shows Promise for Black Adults

Faith-based weight loss trial compares intermittent fasting to continuous calorie reduction for cancer risk reduction in Black adults.

Clinical Trial
Mar 28, 2026 0
Time-Restricted Eating vs Calorie Restriction Shows Promise for Diabetes Prevention
Metabolic Health

Time-Restricted Eating vs Calorie Restriction Shows Promise for Diabetes Prevention

Australian study compares calorie restriction with time-restricted eating for reducing diabetes and heart disease risk factors.

Clinical Trial
Mar 28, 2026 0
Thorne's Quercetin Phytosome Trial for Metabolic Health Was Terminated Early
Metabolic Health

Thorne's Quercetin Phytosome Trial for Metabolic Health Was Terminated Early

A sponsored 90-day trial of enhanced-absorption quercetin targeting cholesterol, blood sugar, and metabolic age was terminated before completion.

Clinical Trial
Jun 24, 2026 0
NAD Precursor Combo Tested to Boost Muscle Mitochondria in Elderly Adults
Metabolic Health

NAD Precursor Combo Tested to Boost Muscle Mitochondria in Elderly Adults

Maastricht University investigated whether NA, NAM, and tryptophan together could restore mitochondrial function in physically compromised older adults.

Clinical Trial
May 8, 2026 0
CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial
Metabolic Health

CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial

Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.

Clinical Trial
Jun 16, 2026 0
Smart Insulin Pen Improves Blood Sugar Management in Type 1 Diabetes Patients
Metabolic Health

Smart Insulin Pen Improves Blood Sugar Management in Type 1 Diabetes Patients

411-person study shows digital insulin delivery system helps optimize glucose control through automated dose tracking and mobile integration.

Clinical Trial
Mar 28, 2026 0
Commitment Devices Boost Intermittent Fasting Adherence in Hypertensive Adults
Metabolic Health

Commitment Devices Boost Intermittent Fasting Adherence in Hypertensive Adults

University of Pennsylvania study tests behavioral tools to help people stick with time-restricted eating for blood pressure and weight management.

Clinical Trial
Mar 28, 2026 0
Page 1 of 2Next